• Mashup Score: 1

    Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. Platelet function testing is a key part of diagnosing platelet function disorders. Yet, a single, readily available, easy-to-implement clinical test is not available to diagnose the wide spectrum of inherited platelet disorders, many of which are caused by unidentified genes. Instead, hematologists rely on a combination of tests that are not available at every institution. “In many areas of the world, it’s

    Tweet Tweets with this article
    • Though #platelet function testing is critical to diagnose platelet function disorders, it requires a combination of tests that are not yet widely accessible. In this month’s Demystifying the Lab, experts discuss the pros and cons of available testing . https://t.co/jJEYWzRxbh

  • Mashup Score: 0

    PF4 partially reset the immune system, lowering levels of other proteins that promote inflammation, and boosted cognition in elderly mice.

    Tweet Tweets with this article
    • A Surprising New Protein Player Restores #Memory in Old Mice https://t.co/f6rUqcb39Z via @SingularityHub #PF4 #neurons #learning #Platelet factors attenuate #inflammation and rescue cognition in #ageing https://t.co/JRtunl4dsR #CXCR3 Platelet factors are induced by #longevity… https://t.co/yqDyi3z20y

  • Mashup Score: 1

    Published: March 23, 2022Updated: April 8, 2022At Dana-Farber Brigham Cancer Center, your health and safety, along with the health and safety of our staff, are our top priorities. The Kraft Family Blood Donor Center at Dana-Farber Cancer Institute and Brigham and Women’s Hospital is continuing to accept blood and platelet donors in a safe and … Read more

    Tweet Tweets with this article
    • #DidYouKnow that January is #NationalBloodDonorMonth? The Kraft Family Blood Donor Center at Dana-Farber Cancer Institute and Brigham and Women’s Hospital is continuing to accept #blood and #platelet donors in a safe and controlled environment. https://t.co/3sp3r1YraT

  • Mashup Score: 1

    In this issue of Blood, Sugimoto et al1 report the result of the first clinical trial of an autologous transfusion of induced pluripotent stem cell (iPSC)-deriv

    Tweet Tweets with this article
    • This is a great short editorial in @BloodJournal placing the letter to the editor about the use of in vitro generated platelets in the first patient in context. The potential is enormous, but costs and upscaling will need to be resolved first. #platelet https://t.co/imKnXy4LVL https://t.co/o8b017bAw1